LUCAS BOONE: Open Payments
NPI 1134651102 · DAPHNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,244 in 61 payments from 7 companies in 2025. Trend: 2023 $2,547 · 2024 $1,685 · 2025 $1,244
Food & beverage: $1,241Education: $4
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 25 | $410 |
| Neurocrine BioSciences, Inc. | 10 | $269 |
| Otsuka America Pharmaceutical, Inc. | 9 | $179 |
| Alkermes, Inc. | 8 | $178 |
| Teva Pharmaceuticals USA, Inc. | 4 | $98 |
| Lundbeck LLC | 4 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
Products named: COBENFY, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, UZEDY, ABILIFY MAINTENA, REXULTI, CAPLYTA.
Industry payments across AL — which companies pay providers there.
